Rabourn Amy Zaremba, Head of Fin. Quality Assurance at Opus Genetics, Inc. (IRD), sold 1,641 shares at $5.20 ($9K) on 2026-04-23, disclosed to the SEC on 2026-04-27.
Open-market sale of $9k IRD by Head of Fin. Quality Assurance. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.